Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

GSK (GSK) stock is in focus as the company is nearing a $1B deal to acquire IDRx, a private biotech focused on a rare ...

Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, ...

The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P.

Robert F. Kennedy, Jr. and I do not have much in common.He grew up on his family’s estate, Hickory Hill, in Virginia. I grew up on a 2-block street in Haymount. He had 10 siblings. I have 1. Our ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

A/S (Nasdaq: ASND) today announced that company executives will participate in the 43rd Annual J.P. Morgan Healthcare ...

Pharmaceutical companies are raising the price of over 250 brand drugs this year. Nearly all the price increases are under 10 ...